SNCA and Parkinson disease: Increasing scientific evidence obtained from both preclinical and human studies suggested that microglia activation occurs in the PD preclinical stages, even before the α-synuclein aggregation and DAergic neurons degeneration, suggesting that the activated microglia contribute to the pathological α-synuclein aggregation.